openPR Logo
Press release

SMi release exclusive interview ahead of Paediatric Clinical Trials 2017: Larissa Kerecuk, Rare Disease Lead, The Birmingham Children’s Hospital

01-30-2017 04:40 PM CET | Health & Medicine

Press release from: SMi Group

Paediatric Clinical Trials

Paediatric Clinical Trials

The leading industry event ‘Paediatric Clinical Trials’ returns to London on 20th-21st March 2017 for its 11th annual show and is delighted to have Larissa Kerecuk as one of the keynote speakers.

In the run up to this year’s event, SMi Group caught up with Larissa to discuss the current landscape of the industry as well as her upcoming presentation entitled ‘Paediatric rare disease research: Challenges & opportunities’. Her presentation will discuss why research into rare diseases is crucial and how care is organised for paediatric patients. She will also explore the challenges and opportunities associated with research into these diseases and why research should be an integral part of care for patients.

“SMi: What do you think the future holds for paediatric clinical trials in the EU and beyond?

LK: In order to ensure that children with rare diseases, which are often life limiting and threatening, obtain the best care they deserve we need to ensure that health care providers, academia and industry throughout the world collaborate to undertake high quality trials which provide meaningful results, and that the results of these trials are rapidly incorporated into patient care. The fantastic improvements seen in cancer treatments have resulted from following this model and there is no reason why it should not work in those with rare diseases as well. The current EU situation is challenging but whenever there are challenges, there are also opportunities to streamline systems that have become counterproductive.”

The full interview is available to access in the event download centre along with several other interviews from this year’s interview series. www.paediatric-trials.co.uk/openpr

The line-up joining Larissa Kerecuk at Paediatric Clinical Trials include handpicked international speakers from EMA, GSK, Insys Therapeutics, Roche, Otsuka and many more as they discuss the topics of regulation, drug development, incentives and recruitment and retention.

For those who are interested in attending register online at the event website www.paediatric-trials.co.uk/openpr

Paediatric Clinical Trials
20-21 March 2017
Copthorne Tara Hotel, London, UK
www.paediatric-trials.co.uk/openpr
Sponsorship enquiries: Contact Alia Malick on: +44 (0) 20 7827 6168 or email amalick@smi-online.co.uk
Group bookings: Contact Ameenah Begum on: +44 (0) 20 7827 6166 or email abegum@smi-online.co.uk
--- END ---

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Ground & First Floor
1 Westminster Bridge Road
London, SE1 7XW

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SMi release exclusive interview ahead of Paediatric Clinical Trials 2017: Larissa Kerecuk, Rare Disease Lead, The Birmingham Children’s Hospital here

News-ID: 424183 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Paediatric

Paediatric Vaccine Market - Industry Trends and Forecast to 2029
The Global Paediatric Vaccine Market Growth at a rate of 9.80% in the forecast period 2022 to 2029. Global Paediatric Vaccine Market Size The paediatric vaccines are used to prevent children from contracting several infectious and non-infectious diseases. The prevalence of chronic diseases is escalating the growth of the paediatric vaccine market. Global paediatric vaccine market was valued at USD 35.74 billion in 2021 and is expected to reach USD 68.78 billion by
Research focused on the Paediatric Vaccine Market forecast to 2026
Paediatric Vaccine Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics. "Paediatric
Paediatric Sports Medicine Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Paediatric Sports Medicine Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-paediatric-sports-medicine-market_p104058.html   Paediatric specialist treat the unique sports-related medical
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
Paediatric Healthcare-Rising Prevalence of Chronic Diseases and Increasing Deman …
Market Research Future published a Half Cooked research report on “Middle East & Africa Paediatric Healthcare Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023. Paediatrics is a branch of medicine which deals with diagnosis and treatment of diseases related to paediatric group. It can be classified into the four categories namely neonates (from birth till the first 28 days of life), infants
Improving Access to Innovative Paediatric Medicines
Paediatric Clinical Trials 2018 recognises the continuing need for education amongst Clinical Research Professionals responsible for the activities at the research site or institution. Next year's event will focus on assisting Research Professionals in improving their skills and their understanding of the responsibilities of conducting clinical research in the paediatric population. Through a series of presentations, practical applications and a supporting workshop facilitated by clinical research professionals, information will be presented